INTERLEUKIN-2 THERAPY FOR METASTATIC UVEAL MELANOMA

被引：23

作者：

DORVAL, T

FRIDMAN, WH

MATHIOT, C

POUILLART, P

机构：

[1] INST CURIE,IMMUNOL CELLULAIRE & CLIN LAB,F-75231 PARIS,FRANCE

[2] INST CURIE,INSERM,U255,F-75231 PARIS,FRANCE

[3] INST CURIE,HEMATOL LAB,F-75231 PARIS,FRANCE

来源：

EUROPEAN JOURNAL OF CANCER | 1992年 / 28A卷 / 12期

关键词：

D O I：

10.1016/0959-8049(92)90266-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2087 / 2087

页数：1

共 11 条

[1]

DORVAL T, 1992, Biotechnology Therapeutics, V3, P63

[2]

EINHORN LH, 1974, CANCER, V34, P1001, DOI 10.1002/1097-0142(197410)34:4<1001::AID-CNCR2820340406>3.0.CO

[3]

2-Z

[4] INTERLEUKIN-2 THERAPY IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA - A PHASE-II STUDY [J].

PARKINSON, DR ;

ABRAMS, JS ;

WIERNIK, PH ;

RAYNER, AA ;

MARGOLIN, KA ;

VANECHO, DA ;

SZNOL, M ;

DUTCHER, JP ;

ARONSON, FR ;

DOROSHOW, JH ;

ATKINS, MB ;

HAWKINS, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (10) :1650-1656

[5]

RAJPAL S, 1983, CANCER, V52, P334, DOI 10.1002/1097-0142(19830715)52:2<334::AID-CNCR2820520225>3.0.CO

[6]

2-E

[7] A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE [J].

ROSENBERG, SA ;

LOTZE, MT ;

MUUL, LM ;

CHANG, AE ;

AVIS, FP ;

LEITMAN, S ;

LINEHAN, WM ;

ROBERTSON, CN ;

LEE, RE ;

RUBIN, JT ;

SEIPP, CA ;

SIMPSON, CG ;

WHITE, DE .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) :889-897

[8]

SEDDON JM, 1989, RETINA, V1, P663

[9]

SPIEGEL JP, 1991, J CLIN ONCOL, V9, P694

[10] SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-2 AND DACARBAZINE IN METASTATIC MELANOMA - A MULTICENTER PHASE-II STUDY [J].

STOTER, G ;

AAMDAL, S ;

RODENHUIS, S ;

CLETON, FJ ;

IACOBELLI, S ;

FRANKS, CR ;

OSKAM, R ;

SHILONI, E .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) :1687-1691

← 1 2 →